Sunovion Respiratory Development Inc.: Clinical Trials

1 trial sponsored by Sunovion Respiratory Development Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Sunovion Respiratory Development Inc.: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
SUN-101 via eFlow nebulizer, SUN-101 via eFlow nebulizer with activated charcoal, Seebri® Breezhaler® - COPD
Phase 1CompletedSunovion Respiratory Development Inc.302015-10-012018-10-25

Conditions studied

Pulmonary Disease, Chronic Obstructive (1)

Interventions

Charcoal (1)  ·  Glycopyrrolate (1)

Countries

United Kingdom (1)

Results publications

PMID 31253162